Mar 23, 2019 - The markets have been on a steady upward move since the beginning of this year. Yet, it is still 4% below its all-time high.Irrespective of market direction or sentiment, it's always a good idea to ke
Mar 20, 2019 - AbbVie and Roche have trouble with Venclexta as partial clinical hold is placed.Merck KGaA And Pfizer suffer a bad luck streak after latest Bavencio trial Failure.Puma Biotechnology announces positive
Mar 20, 2019 - YCharts tracks ten point Value and Fundamental scores as a Y Rating system for 21,846 equities. Dividend payers posting 6-10 points in both categories made this Valu list as screened 3/18/19.Top ten b
Mar 20, 2019 - AbbVie has established itself as a long-term dividend stock with regular dividend increases.The market, primarily focused on the accelerating decline in Humira revenues, punishes the stock.The overall
Mar 18, 2019 - The S&P 500 is up 13% YTD despite a drastically slowing economy and falling EPS growth expectations.It's becoming harder to find good places to invest new money, but quality companies at attractive pr
Mar 18, 2019 - I'm testing a new model portfolio called BDGP, designed to deliver safe and growing dividends no matter what the economy or stock market does.It is 100% made up of dividend aristocrats and kings, whic
Mar 17, 2019 - The big-pharma company could be in much better shape than you think.
Mar 15, 2019 - Kiplinger Today, a daily digest of timely, trusted advice, regularly lists hundreds of opportune stocks and funds for investors. This Potpourri was collected over the past three months.Kiplinger favor
Mar 14, 2019 - Roche (RHHBY) gets approval from European Commission for a label expansion of hemophilia drug, Hemlibra.
Mar 13, 2019 - AbbVie, Inc. (NYSE:ABBV) Barclays Global Healthcare Conference March 13, 2019, 10:15 ET Company Participants Robert Michael - SVP & CFO Michael Severino - Vice Chairman & President Conference